Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimally Invasive, Fertility-Sparing Surgical Management of Multiple Bilateral Ovarian Dermoid Cysts.

Fertility and sterility·2026
Same author

Association of embryo transfer catheter maneuvers on clinical pregnancy and live birth.

Journal of assisted reproduction and genetics·2026
Same author

The importance of cycle review meetings.

Fertility and sterility·2026
Same author

Where mind meets embryo: antidepressants in assisted reproductive technology.

Fertility and sterility·2026
Same author

Between signal and noise: ejaculatory abstinence and embryo mosaicism.

Fertility and sterility·2026
Same author

Should you do ultrasound monitoring and trigger for intrauterine insemination cycles?

Fertility and sterility·2026
Same journal

Confronting complexities of uterus transplantation: Balancing Innovation, Risk and Access.

Fertility and sterility·2026
Same journal

Fertility Benefits and Parental Leave Policies across Accreditation Council for Graduate Medical Education (ACGME) Programs with Ob/Gyn Residency Programs.

Fertility and sterility·2026
Same journal

Hormonal and metabolic effects of the administration of oral low-dose 17-β-estradiol (0.2 mg) in patients with Functional Hypothalamic Amenorrhea (FHA): A Retrospective Pilot Study.

Fertility and sterility·2026
Same journal

Biomarker or Bystander? Considering Triglyceride Glucose-Body Mass Index (TyG-BMI) in Patients with Polyendocrine Metabolic Ovarian Syndrome.

Fertility and sterility·2026
Same journal

The Importance of the Incubator: Perinatal Outcomes following Intravaginal Culture.

Fertility and sterility·2026
Same journal

Segmental Aneuploidy in Human Preimplantation Embryos: Toward a Clinical Framework Based on Meiotic Versus Mitotic Origin.

Fertility and sterility·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Optimizing the therapeutic donor insemination cycle.

Jeremy Applebaum1, Elizabeth S Ginsburg1

  • 1Center for Infertility and Reproductive Surgery, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Fertility and Sterility
|July 4, 2026
PubMed
Summary
This summary is machine-generated.

Therapeutic donor insemination (TDI) cycle management should prioritize patient-centered, minimally burdensome strategies. Evidence suggests comparable outcomes with various ovulation monitoring methods and limited benefit from routine luteal support in most cases.

Keywords:
intrauterine inseminationovulation inductiontherapeutic donor insemination

More Related Videos

Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

U-Shaped Horizontal Swimming Technique for Preparing High-Quality Sperm with Low DNA Fragmentation Index
09:16

U-Shaped Horizontal Swimming Technique for Preparing High-Quality Sperm with Low DNA Fragmentation Index

Published on: March 28, 2025

Related Experiment Videos

Last Updated: Jul 6, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

U-Shaped Horizontal Swimming Technique for Preparing High-Quality Sperm with Low DNA Fragmentation Index
09:16

U-Shaped Horizontal Swimming Technique for Preparing High-Quality Sperm with Low DNA Fragmentation Index

Published on: March 28, 2025

Area of Science:

  • Reproductive Medicine
  • Infertility Treatment
  • Assisted Reproductive Technologies

Background:

  • Therapeutic donor insemination (TDI) is a common fertility treatment.
  • Cycle management in TDI often relies on institutional preference over definitive evidence.
  • Optimizing pregnancy outcomes requires balancing efficacy, cost, access, and patient burden.

Purpose of the Study:

  • To review current evidence on therapeutic donor insemination (TDI) cycle management.
  • To assess strategies for optimizing insemination timing and ovulation monitoring.
  • To evaluate the role of ovulation induction and luteal phase support in TDI.

Main Methods:

  • Review of current evidence on TDI cycle management strategies.
  • Analysis of different ovulation monitoring techniques (LH detection, serum monitoring, ultrasound).
  • Evaluation of outcomes associated with ovulation induction and luteal phase support.

Main Results:

  • Comparable pregnancy outcomes are observed across different ovulation monitoring methods in most ovulatory patients.
  • Natural-cycle TDI demonstrates favorable cumulative pregnancy rates.
  • Oral ovulation induction offers modest pregnancy benefits but increases multiple gestation risk; luteal phase support is not routinely recommended.

Conclusions:

  • A patient-centered approach to TDI cycle management is supported by evidence.
  • Minimally burdensome and effective strategies should be prioritized.
  • Individualized decisions regarding ovulation induction are warranted, and routine luteal support is not advised.